Diacylglycerol Kinase ζ (DGKζ) Is a Critical Regulator of Bone Homeostasis Via Modulation of c-Fos Levels in Osteoclasts
Open Access
- 18 April 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 30 (10) , 1852-1863
Abstract
Increased diacylglycerol (DAG) levels are observed in numerous pathologies, including conditions associated with bone loss. However, the effects of DAG accumulation on the skeleton have never been directly examined. Because DAG is strictly controlled by tissue‐specific diacylglycerol kinases (DGKs), we sought to examine the biological consequences of DAG accumulation on bone homeostasis by genetic deletion of DGKζ, a highly expressed DGK isoform in osteoclasts (OCs). Strikingly, DGKζ‐/‐ mice are osteoporotic because of a marked increase in OC numbers. In vitro, DGKζ‐/‐ bone marrow macrophages (BMMs) form more numerous, larger, and highly resorptive OCs. Surprisingly, although increased DAG levels do not alter receptor activator of NF‐κB (RANK)/RANK ligand (RANKL) osteoclastogenic pathway, DGKζ deficiency increases responsiveness to the proliferative and pro‐survival cytokine macrophage colony‐stimulating factor (M‐CSF). We find that M‐CSF is responsible for increased DGKζ‐/‐ OC differentiation by promoting higher expression of the transcription factor c‐Fos, and c‐Fos knockdown in DGKζ‐/‐ cultures dose‐dependently reduces OC differentiation. Using a c‐Fos luciferase reporter assay lacking the TRE responsive element, we also demonstrate that M‐CSF induces optimal c‐Fos expression through DAG production. Finally, to demonstrate the importance of the M‐CSF/DGKζ/DAG axis on regulation of c‐Fos during osteoclastogenesis, we turned to PLCγ2+/‐ BMMs, which have reduced DAG levels and form fewer OCs because of impaired expression of the master regulator of osteoclastogenesis NFATc1 and c‐Fos. Strikingly, genetic deletion of DGKζ in PLCγ2+/‐ mice rescues OC formation and normalizes c‐Fos levels without altering NFATc1 expression. To our knowledge, this is the first report implicating M‐CSF/DGKζ/DAG axis as a critical regulator of bone homeostasis via its actions on OC differentiation and c‐Fos expression. © 2015 American Society for Bone and Mineral Research.Keywords
This publication has 46 references indexed in Scilit:
- Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorptionBMC Musculoskeletal Disorders, 2010
- c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritisArthritis Research & Therapy, 2010
- Phospholipase C Gamma 2 Is Critical for Development of a Murine Model of Inflammatory Arthritis by Affecting Actin Dynamics in Dendritic CellsPLOS ONE, 2010
- Phospholipase Cγ2 Modulates Integrin Signaling in the Osteoclast by Affecting the Localization and Activation of Src KinaseMolecular and Cellular Biology, 2008
- Increased expression of macrophage colony-stimulating factor in ankylosing spondylitis and rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2Journal of Clinical Investigation, 2006
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Activation of the c-fos enhancer by the Erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sitesOncogene, 2000
- Fosl1 is a transcriptional target of c-Fos during osteoclast differentiationNature Genetics, 2000
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959